Poor Prognosis of COVID‐19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross‐Sectional Population Study Of 252 119 Patients
Objective Coronavirus disease 2019 (COVID‐19) has progressed rapidly around the world, reaching a lethality of up to 20% due to acute respiratory distress syndrome (ARDS). This latter condition is a relevant concern for systemic lupus erythematosus (SLE); however, data on this topic are limited to f...
Guardado en:
Autores principales: | Isabela Maria Bertoglio, Juliana Miranda de Lucena Valim, Danielle Daffre, Nádia Emi Aikawa, Clovis Artur Silva, Eloisa Bonfá, Michelle Remião Ugolini‐Lopes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32332e12575d431f8388e2518d097e48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sjögren's syndrome and systemic lupus erythematosus: links and risks
por: Pasoto SG, et al.
Publicado: (2019) -
The prevalence and incidence of systemic lupus erythematosus in Taiwan: a nationwide population-based study
por: Pui-Ying Leong, et al.
Publicado: (2021) -
Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011) -
Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study
por: Chin-Fang Su, et al.
Publicado: (2021) -
Netosis in patients with systemic lupus erythematosus
por: V. V. Zhelezko, et al.
Publicado: (2020)